Literature DB >> 1347447

The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase.

S P Bottari1, I N King, S Reichlin, I Dahlstroem, N Lydon, M de Gasparo.   

Abstract

The signalling mechanism and cellular targets of the AT2 receptor are still unknown. We report that angiotensin II (Ang II) inhibits basal and atrial natriuretic peptide stimulated particulate guanylate cyclase (pGC) activity through AT2 receptors in rat adrenal glomerulosa and PC12W cells. This inhibition is blocked by the phosphotyrosine phosphatase (PTPase) inhibitor orthovanadate but not by the Ser/Thr phosphatase inhibitor okadaic acid, suggesting the involvement of a PTPase in this process. Moreover, Ang II induces a rapid, transient and orthovanadate sensitive dephosphorylation of phosphotyrosine containing proteins in PC12W cells. Our findings suggest that AT2 receptors signal through stimulation of a PTPase and that this mechanism is implicated in the regulation of pGC activity. This observation is also the first example of hormonal inhibition of basal pGC activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347447     DOI: 10.1016/0006-291x(92)91629-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

1.  Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements.

Authors:  C Warnecke; T Willich; J Holzmeister; S P Bottari; E Fleck; V Regitz-Zagrosek
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

Review 2.  Angiotensin AT2 receptors: cardiovascular hope or hype?

Authors:  Robert E Widdop; Emma S Jones; Ruth E Hannan; Tracey A Gaspari
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

3.  Pharmacological characterization of angiotensin II AT(2) receptor subtype heterogeneity in the rat adrenal cortex and medulla.

Authors:  X Lu; K L Grove; W Zhang; R C Speth
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

Review 4.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 5.  Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.

Authors:  Kailash N Pandey
Journal:  Can J Physiol Pharmacol       Date:  2011-08-04       Impact factor: 2.273

Review 6.  Should we aim at tissue renin-angiotensin systems?

Authors:  J F Smits; R C Passier; M J Daemen
Journal:  Pharm World Sci       Date:  1998-06

Review 7.  The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigms.

Authors:  Kailash N Pandey
Journal:  FEBS J       Date:  2011-04-07       Impact factor: 5.542

8.  Expression cloning of type 2 angiotension II receptor reveals a unique class of seven-transmembrane receptors.

Authors:  K M Curnow
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

9.  Ligand-mediated endocytosis and intracellular sequestration of guanylyl cyclase/natriuretic peptide receptors: role of GDAY motif.

Authors:  Kailash N Pandey
Journal:  Mol Cell Biochem       Date:  2009-11-26       Impact factor: 3.396

10.  Opposite effects of angiotensin II and the protein kinase C activator OAG on cardiac Na+ channels.

Authors:  I Benz; J W Herzig; M Kohlhardt
Journal:  J Membr Biol       Date:  1992-11       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.